Scientific Sessions 2025  /  Cutting Edge Valve and Coronary Trials  /  Discussant: FAVOR 4-QVAS
Logo

American Heart Association

  69
  0

Final ID:

Discussant: FAVOR 4-QVAS

  • De Bruyne, Bernard  ( Cardiovascular Center Aalst , Aalst , Belgium )
  • Nishimura, Rick  ( MAYO CLINIC ROCHESTER , Rochester , Minnesota , United States )
  • Sutton, Nadia  ( Vanderbilt University Medical Cente , Nashville , Tennessee , United States )
  • Tremmel, Jennifer  ( STANFORD UNIVERSITY MEDICAL CENTER , Stanford , California , United States )
  • Kearney, Kathleen  ( UNIVERSITY OF WASHINGTON , Seattle , Washington , United States )
    • Author Disclosures:
    Bernard De Bruyne: No Answer | Rick Nishimura: DO NOT have relevant financial relationships | Nadia Sutton: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Individual Stocks/Stock Options:Stallion, Inc:Active (exists now) ; Consultant:Radiaction:Active (exists now) ; Consultant:Zoll/Therox:Active (exists now) | Jennifer Tremmel: DO have relevant financial relationships ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Edwards:Active (exists now) ; Consultant:Shockwave:Active (exists now) ; Researcher:Shockwave:Active (exists now) ; Consultant:Cordis:Active (exists now) ; Advisor:Abbott:Active (exists now) ; Consultant:Abbott:Active (exists now) ; Advisor:Boston Scientific:Active (exists now) ; Researcher:Boston Scientific:Active (exists now) | Kathleen Kearney: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Advisor:Elixir:Active (exists now) ; Consultant:Phillips:Past (completed) ; Consultant:Asahi:Active (exists now) ; Consultant:Medtronic:Past (completed) ; Consultant:Boston Scientific:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cutting Edge Valve and Coronary Trials

Saturday, 11/08/2025 , 03:15PM - 04:30PM

Late-Breaking Science

More abstracts on this topic:
Discussant: RECOVERY

Otto Catherine

Angiography-derived FFR-Guided Coronary Artery Bypass Grafting for Patients undergoing Valve Surgery with Concomitant Coronary Artery Disease (FAVOR 4-QVAS): a Randomized Trial

Zhu Yunpeng, Guo Zhigang, Zhu Dan, Zhang Xiquan, Chen Liangwan, Redfors Bjorn, Sandner Sigrid, Gaudino Mario, Tu Shengxian, Zhao Qiang, Cheng Zhaoyun, Zhao Yuan, Zhang Wei, Han Lin, Zhang Chengxin, Yang Sumin, Ma Liang, Qiao Chenhui

More abstracts from these authors:
Panel Discussion

Kearney Kathleen

Primary prevention with statins for older adults: Pro

Alexander Karen, Kearney Kathleen

You have to be authorized to contact abstract author. Please, Login
Not Available